Vulvas get a good look in this soon-to-be-published study:
“Interest in Cosmetic Vulvar Surgery and Perception of Vulvar Appearance,” Ladin A. Yurteri-Kaplan, Danielle D. Antosh, Andrew I. Sokol, Amy J. Park, Robert E. Gutman, Sheryl A. Kingsberg, Cheryl B. Iglesia [pictured here], in press at American Journal of Obstetrics & Gynecology. The authors are variously at Georgetown University School of Medicine, Washington, DC, and Case Western Reserve University School of Medicine in Cleveland, Ohio. They write:
Objective: To determine if reproductive-age women are more likely to perceive their vulva as abnormal compared to older aged women.
Study Design: Women ages 18-44 (Group 1) and 45-72 (Group 2) completed a survey on demographics, grooming patterns, vulvar perceptions, and source of information about the vulva.
Results: There was no difference between Group 1 and Group 2 in how often women looked at their vulva or their perception of having a normal vulva (91% vs. 93%, p=0.76). Both groups were satisfied with the appearance of their vulva (81% vs. 82%, p=0.71).
The study carries this statement: “Age does not impact vulvar perception or satisfaction; however, older women more frequently consider cosmetic vulvar surgery.” The study also includes many photographs.
(Thanks to investogator Ivan Oransky for bringing this to our attention.)
BONUS: The document lists possible vulva-related conflicts of interest for one of the co-authors. Specifically: “Disclosures: Sheryl A. Kingsberg serves as consultant for Boehringer-Ingelheim Pharmaceuticals, Inc.; BioSante Pharmaceuticals; Pfizer, Inc.; Trimel BioPharm Inc.; Novo Nordisk; and Sprout. She is on the scientific advisory board for Viveve. She is a clinical investigator for Palatin and BioSante. She owns stock in Viveve. No other authors have any conflicts of interest.”